TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive In Brief: Patterns Of care Study Leads “Part Tie” Radiotherapists To Drop Out, Sheline Says July 22, 1977
TCL Archive Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors July 4, 1997
